PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
171.25%
Net income growth similar to CRON.TO's 163.57%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
5.29%
Less D&A growth vs. CRON.TO's 29.06%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
219.33%
Some yoy growth while CRON.TO is negative at -237.95%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-34.35%
Negative yoy SBC while CRON.TO is 210.92%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-36.33%
Negative yoy working capital usage while CRON.TO is 109.59%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
46.66%
AR growth while CRON.TO is negative at -3473.97%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-39.66%
Negative yoy inventory while CRON.TO is 144.27%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-43.57%
Negative yoy AP while CRON.TO is 279.04%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
25.06%
Some yoy usage while CRON.TO is negative at -439.73%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-138.57%
Both negative yoy, with CRON.TO at -63.30%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-28.58%
Negative yoy CFO while CRON.TO is 28.21%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-39.28%
Negative yoy CapEx while CRON.TO is 2.94%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
241.53%
Acquisition spending well above CRON.TO's 79.38%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
99.97%
Some yoy expansion while CRON.TO is negative at -150.88%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-69.91%
We reduce yoy sales while CRON.TO is 739.86%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-99.96%
Both yoy lines negative, with CRON.TO at -62.37%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-755.57%
We reduce yoy invests while CRON.TO stands at 89.69%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
7.03%
Debt repayment at 75-90% of CRON.TO's 8.29%. Bill Ackman urges more debt clearance to match competitor’s lower leverage.
591.99%
Issuance growth of 591.99% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.